Viewing Study NCT03204968


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2025-12-28 @ 7:03 AM
Study NCT ID: NCT03204968
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2017-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effect of Vagus Nerve Stimulation on the Inflammatory Response After Lung Lobectomy
Sponsor: Otto Wagner Hospital
Organization:

Study Overview

Official Title: The Effect of Vagus Nerve Stimulation on the Inflammatory Response After Lung Lobectomy
Status: COMPLETED
Status Verified Date: 2017-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Systemic inflammation is a potentially debilitating complication of thoracic surgeries that can result in significant physical and economic morbidity for afflicted patients. There is compelling evidence for the role of central nervous system in the regulation of systemic inflammatory responses through humoral mechanisms. Activation of afferent vagus nerve fibers by cytokines triggers anti-inflammatory responses. Direct electrical stimulation of the peripheral vagus nerve in vivo during lethal endotoxemia in rats inhibited Tumor necrosis factor (TNF) synthesis in liver preventing the development of shock. The vagal regulatory role of systemic inflammation after lung lobectomy is unknown.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: